These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9921985

  • 1. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
    Borsellino N, Bonavida B, Ciliberto G, Toniatti C, Travali S, D'Alessandro N.
    Cancer; 1999 Jan 01; 85(1):134-44. PubMed ID: 9921985
    [Abstract] [Full Text] [Related]

  • 2. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N, Belldegrun A, Bonavida B.
    Cancer Res; 1995 Oct 15; 55(20):4633-9. PubMed ID: 7553641
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 4. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999 Jun 24; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

  • 5. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R, Borsellino N, Frost P, Gárban H, Ng CP, Mizutani Y, Belldegrun A, Bonavida B.
    Clin Cancer Res; 1997 Jun 24; 3(6):963-72. PubMed ID: 9815772
    [Abstract] [Full Text] [Related]

  • 6. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
    Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K.
    Cell Growth Differ; 1996 Jul 24; 7(7):923-9. PubMed ID: 8809410
    [Abstract] [Full Text] [Related]

  • 7. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ, Jelinek DF.
    J Immunol; 1996 Oct 01; 157(7):3081-8. PubMed ID: 8816418
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 01; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

  • 9. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ.
    Cancer Lett; 2010 Sep 01; 295(1):110-23. PubMed ID: 20236757
    [Abstract] [Full Text] [Related]

  • 10. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J, Sun RX, Cotte N, Gaillard JP, Mani JC, Klein B, Brochier J.
    Cytokine; 1997 Apr 01; 9(4):233-41. PubMed ID: 9112331
    [Abstract] [Full Text] [Related]

  • 11. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D, Ishihara K, Hirano T.
    Rev Physiol Biochem Pharmacol; 2003 Apr 01; 149():1-38. PubMed ID: 12687404
    [Abstract] [Full Text] [Related]

  • 12. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S, Suzuki E, Ueda H, Makishima F.
    Cytokine; 1996 Dec 01; 8(12):889-94. PubMed ID: 9050746
    [Abstract] [Full Text] [Related]

  • 13. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA, Brailly H, Sautès C, Joyeux I, Dorval T, Mosseri V, Yasukawa K, Wijdenes J, Adler A, Gorin I, Fridman WH, Tartour E.
    Clin Cancer Res; 1997 Aug 01; 3(8):1443-51. PubMed ID: 9815830
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
    Sammons J, Ahmed N, Khokher MA, Hassan HT.
    Stem Cells; 2000 Aug 01; 18(3):214-9. PubMed ID: 10840075
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z.
    Prostate; 2005 Jul 01; 64(2):209-16. PubMed ID: 15712220
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
    Howlett M, Judd LM, Jenkins B, La Gruta NL, Grail D, Ernst M, Giraud AS.
    Gastroenterology; 2005 Sep 01; 129(3):1005-18. PubMed ID: 16143138
    [Abstract] [Full Text] [Related]

  • 17. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I, Horsten U, Pflanz S, Dahmen H, Küster A, Grötzinger J, Heinrich PC, Müller-Newen G.
    J Immunol; 1999 Feb 01; 162(3):1480-7. PubMed ID: 9973404
    [Abstract] [Full Text] [Related]

  • 18. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F, Kinzie E, Wang Y, Duplomb L, Godard A, Held WA, Asch BB, Baumann H.
    Oncogene; 2002 Sep 12; 21(41):6264-77. PubMed ID: 12214267
    [Abstract] [Full Text] [Related]

  • 19. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M, Richards CD, Gauldie J.
    Cytokine; 1995 Aug 12; 7(6):503-9. PubMed ID: 8580365
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX, Gennaro C, Rocco S, Gu ZJ, Klein B.
    Eur Cytokine Netw; 1997 Mar 12; 8(1):51-6. PubMed ID: 9110148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.